Effects of Different Types and Combinations of Antimicrobial Agents on Endotoxin Release from Gram-negative Bacteria: An In-Vitro and In-Vivo Study
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 23 (6) , 745-754
- https://doi.org/10.3109/00365549109024303
Abstract
Total and free endotoxin release in time from cultures of Escherichia coli by different antibiotics was studied in vitro for 4 h in relation to the antibiotic effect on viable counts and morphological features of the test cultures. The most rapid fall in viable counts was seen after treatment with imipenem or the combination of imipenem with tobramycin, accompanied by an early, but minimal increase (1.8-fold) of the total (free plus cell-bound) endotoxin level at 1 h. Total endotoxin levels increased approximately 5-fold upon incubation with ceftazidime, tobramycin or the combination of tobramycin with cefuroxime, whereas incubation with cefuroxime or aztreonam alone caused a late 22-and 49-fold increase in total endotoxin, respectively, at 4 h. In chloramphenicol treated cultures there was still an increase in viable counts during therapy, resulting in an ultimately 78-fold increase of mean levels of total endotoxin. Free endotoxin levels increased approximately 6-fold within 1 h upon treatment with imipenem, alone or in combination with tobramycin, or ceftazidime as the result of rapid lysis of bacteria. Treatment with cefuroxime or aztreonam induced a relatively late but much higher release of free endotoxin (118-and 222-fold, respectively), which was due to the formation of long filamentous structures during the first 2 h of incubation and eventually cell lysis. Both tobramycin and the combination of tobramycin with cefuroxime caused a more gradual rise in free endotoxin, with a ± 15-fold increase in free endotoxin at 4 h. In chloramphenicol treated cultures, as in the control cultures, the level of free endotoxin remained proportional to the amount of viable organisms. We also studied plasma endotoxin levels in 20 patients with septic shock. 10 out of these 20 patients had a detectable endotoxemia (>5 ng/l) on admission. We describe the patterns of plasma endotoxin in these patients during the first 24 h of antibiotic treatment. We conclude that, in the in-vitro study, values of total endotoxin, free endotoxin, and the rate of release of endotoxin varies with the antibiotic used. We also demonstrate that in patients under treatment for septic shock endotoxin release can be related to the administration of antibiotics.Keywords
This publication has 21 references indexed in Scilit:
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.The Journal of Experimental Medicine, 1989
- Serial Quantitation of Endotoxemia and Bacteremia During Therapy for Gram-Negative Bacterial SepsisThe Journal of Infectious Diseases, 1988
- Antibiotic Therapy, Endotoxin Concentration in Cerebrospinal Fluid, and Brain Edema in Experimental Escherichia coli Meningitis in RabbitsThe Journal of Infectious Diseases, 1987
- Stability of tobramycin in combination with selected new β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1986
- Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- ANTIBIOTIC-INDUCED ENDOTOXIN RELEASEThe Lancet, 1985
- Effect of Benzylpenicillin in Mice Infected with Endotoxin-liberating or Non-liberating Variant Strains of Neisseria meningitidisScandinavian Journal of Infectious Diseases, 1984
- The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial EndotoximThe Journal of Infectious Diseases, 1980
- TOO-RAPID DESTRUCTION OF GRAM-NEGATIVE ORGANISMSThe Lancet, 1977